Nine species (240 strains) of gram-negative ... of this type of antibiotic therapy. The role of penicillin G in the management of serious infections caused by gram-negative bacilli is examined ...

Results from studies that evaluate combination therapy versus monotherapy for gram-negative bacilli conflict with ... Antimicrobial overuse may lead to antibiotic resistance, unnecessary adverse ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

All patients met the following diagnostic criteria: demonstration of gram-negative rods ... twenty-four hours. Treatment was divided into 3 stages: administration of antibiotic drugs and large ...

Aerobic gram-negative bacilli including P aeruginosa are increasingly ... Based upon this probable spectrum of inciting pathogens the following antibiotic regimens are recommended: a second ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ...